These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25981932)

  • 1. Anti-tumour effect of metformin in canine mammary gland tumour cells.
    Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
    Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic screening of a library of compounds against metastatic and non-metastatic clones of a canine mammary gland tumour cell line.
    Saeki K; Watanabe M; Michishita M; Tsuboi M; Sugano S; Yoshitake R; Murai K; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
    Vet J; 2015 Aug; 205(2):288-96. PubMed ID: 25975851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
    O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
    Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
    Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
    PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neoplastic effects of topoisomerase inhibitors in canine mammary carcinoma, melanoma, and osteosarcoma cell lines.
    Ong SM; Yamamoto H; Saeki K; Tanaka Y; Yoshitake R; Nishimura R; Nakagawa T
    Jpn J Vet Res; 2017 Feb; 65(1):17-28. PubMed ID: 29791117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a pair of novel cloned tumour cell lines with or without metastatic potential from canine mammary adenocarcinoma.
    Murai K; Nakagawa T; Endo Y; Kamida A; Yoshida K; Mochizuki M; Nishimura R; Sasaki N
    Res Vet Sci; 2012 Aug; 93(1):468-72. PubMed ID: 21714977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effects of rivoceranib against canine melanoma and mammary gland tumour in vitro and in vivo mouse xenograft models.
    Li Q; Kim YS; An JH; Kwon JA; Han SH; Song WJ; Youn HY
    BMC Vet Res; 2021 Oct; 17(1):338. PubMed ID: 34702279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NF-κB expression and its inhibition on canine mammary cancer cell lines in an immunodeficient mice model.
    Mkaouar L; Endo Y; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
    J Vet Med Sci; 2011 Dec; 73(12):1539-46. PubMed ID: 21768753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice.
    Zheng S; Liu J; Han Q; Huang S; Su W; Fu J; Jia X; Du S; Zhou Y; Zhang X; Guan Y
    J Diabetes; 2014 Mar; 6(2):132-46. PubMed ID: 24405721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent.
    Chung MM; Chen YL; Pei D; Cheng YC; Sun B; Nicol CJ; Yen CH; Chen HM; Liang YJ; Chiang MC
    Biochim Biophys Acta; 2015 May; 1852(5):720-31. PubMed ID: 25595658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
    Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
    J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anti-melanoma action of metformin.
    Janjetovic K; Harhaji-Trajkovic L; Misirkic-Marjanovic M; Vucicevic L; Stevanovic D; Zogovic N; Sumarac-Dumanovic M; Micic D; Trajkovic V
    Eur J Pharmacol; 2011 Oct; 668(3):373-82. PubMed ID: 21806981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells.
    Wang Q; Cai Y; Van de Casteele M; Pipeleers D; Ling Z
    J Endocrinol; 2011 Feb; 208(2):161-9. PubMed ID: 21084384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
    Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.
    Li B; Takeda T; Tsuiji K; Kondo A; Kitamura M; Wong TF; Yaegashi N
    Gynecol Endocrinol; 2013 Jan; 29(1):87-90. PubMed ID: 22835064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
    Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
    Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.